Global CRISPR and Cas Genes 麻豆原创 Research Report 2023

Publication ID:

PB503235753

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global CRISPR and Cas Genes market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for CRISPR and Cas Genes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for CRISPR and Cas Genes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for CRISPR and Cas Genes in Genome Engineering is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of CRISPR and Cas Genes include Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, Merck, Integrated DNA Technologies, Inc., Transposagen Biopharmaceuticals, Inc., OriGene Technologies, Inc. and New England Biolabs, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR and Cas Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR and Cas Genes.
The CRISPR and Cas Genes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global CRISPR and Cas Genes market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR and Cas Genes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Synthego
Thermo Fisher Scientific, Inc.
GenScript
Addgene
Merck
Integrated DNA Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.
OriGene Technologies, Inc.
New England Biolabs
Horizon Discovery Group Co.
Cellecta, Inc.
Agilent Technologies
Applied StemCell, Inc.
Segment by Type
Vector-based Cas
DNA-free Cas
Segment by Application
Genome Engineering
Disease Models
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR and Cas Genes companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global CRISPR and Cas Genes 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vector-based Cas
1.2.3 DNA-free Cas
1.3 麻豆原创 by Application
1.3.1 Global CRISPR and Cas Genes 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Genome Engineering
1.3.3 Disease Models
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and Cas Genes 麻豆原创 Perspective (2018-2029)
2.2 CRISPR and Cas Genes Growth Trends by Region
2.2.1 Global CRISPR and Cas Genes 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 CRISPR and Cas Genes Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 CRISPR and Cas Genes Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 CRISPR and Cas Genes 麻豆原创 Dynamics
2.3.1 CRISPR and Cas Genes Industry Trends
2.3.2 CRISPR and Cas Genes 麻豆原创 Drivers
2.3.3 CRISPR and Cas Genes 麻豆原创 Challenges
2.3.4 CRISPR and Cas Genes 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR and Cas Genes Players by Revenue
3.1.1 Global Top CRISPR and Cas Genes Players by Revenue (2018-2023)
3.1.2 Global CRISPR and Cas Genes Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global CRISPR and Cas Genes 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR and Cas Genes Revenue
3.4 Global CRISPR and Cas Genes 麻豆原创 Concentration Ratio
3.4.1 Global CRISPR and Cas Genes 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR and Cas Genes Revenue in 2022
3.5 CRISPR and Cas Genes Key Players Head office and Area Served
3.6 Key Players CRISPR and Cas Genes Product Solution and Service
3.7 Date of Enter into CRISPR and Cas Genes 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and Cas Genes Breakdown Data by Type
4.1 Global CRISPR and Cas Genes Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global CRISPR and Cas Genes Forecasted 麻豆原创 Size by Type (2024-2029)
5 CRISPR and Cas Genes Breakdown Data by Application
5.1 Global CRISPR and Cas Genes Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global CRISPR and Cas Genes Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America CRISPR and Cas Genes 麻豆原创 Size (2018-2029)
6.2 North America CRISPR and Cas Genes 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CRISPR and Cas Genes 麻豆原创 Size by Country (2018-2023)
6.4 North America CRISPR and Cas Genes 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR and Cas Genes 麻豆原创 Size (2018-2029)
7.2 Europe CRISPR and Cas Genes 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CRISPR and Cas Genes 麻豆原创 Size by Country (2018-2023)
7.4 Europe CRISPR and Cas Genes 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR and Cas Genes 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific CRISPR and Cas Genes 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CRISPR and Cas Genes 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific CRISPR and Cas Genes 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR and Cas Genes 麻豆原创 Size (2018-2029)
9.2 Latin America CRISPR and Cas Genes 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CRISPR and Cas Genes 麻豆原创 Size by Country (2018-2023)
9.4 Latin America CRISPR and Cas Genes 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR and Cas Genes 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa CRISPR and Cas Genes 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CRISPR and Cas Genes 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa CRISPR and Cas Genes 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Synthego
11.1.1 Synthego Company Detail
11.1.2 Synthego Business Overview
11.1.3 Synthego CRISPR and Cas Genes Introduction
11.1.4 Synthego Revenue in CRISPR and Cas Genes Business (2018-2023)
11.1.5 Synthego Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Detail
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. CRISPR and Cas Genes Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in CRISPR and Cas Genes Business (2018-2023)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 GenScript
11.3.1 GenScript Company Detail
11.3.2 GenScript Business Overview
11.3.3 GenScript CRISPR and Cas Genes Introduction
11.3.4 GenScript Revenue in CRISPR and Cas Genes Business (2018-2023)
11.3.5 GenScript Recent Development
11.4 Addgene
11.4.1 Addgene Company Detail
11.4.2 Addgene Business Overview
11.4.3 Addgene CRISPR and Cas Genes Introduction
11.4.4 Addgene Revenue in CRISPR and Cas Genes Business (2018-2023)
11.4.5 Addgene Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck CRISPR and Cas Genes Introduction
11.5.4 Merck Revenue in CRISPR and Cas Genes Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Integrated DNA Technologies, Inc.
11.6.1 Integrated DNA Technologies, Inc. Company Detail
11.6.2 Integrated DNA Technologies, Inc. Business Overview
11.6.3 Integrated DNA Technologies, Inc. CRISPR and Cas Genes Introduction
11.6.4 Integrated DNA Technologies, Inc. Revenue in CRISPR and Cas Genes Business (2018-2023)
11.6.5 Integrated DNA Technologies, Inc. Recent Development
11.7 Transposagen Biopharmaceuticals, Inc.
11.7.1 Transposagen Biopharmaceuticals, Inc. Company Detail
11.7.2 Transposagen Biopharmaceuticals, Inc. Business Overview
11.7.3 Transposagen Biopharmaceuticals, Inc. CRISPR and Cas Genes Introduction
11.7.4 Transposagen Biopharmaceuticals, Inc. Revenue in CRISPR and Cas Genes Business (2018-2023)
11.7.5 Transposagen Biopharmaceuticals, Inc. Recent Development
11.8 OriGene Technologies, Inc.
11.8.1 OriGene Technologies, Inc. Company Detail
11.8.2 OriGene Technologies, Inc. Business Overview
11.8.3 OriGene Technologies, Inc. CRISPR and Cas Genes Introduction
11.8.4 OriGene Technologies, Inc. Revenue in CRISPR and Cas Genes Business (2018-2023)
11.8.5 OriGene Technologies, Inc. Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs CRISPR and Cas Genes Introduction
11.9.4 New England Biolabs Revenue in CRISPR and Cas Genes Business (2018-2023)
11.9.5 New England Biolabs Recent Development
11.10 Horizon Discovery Group Co.
11.10.1 Horizon Discovery Group Co. Company Detail
11.10.2 Horizon Discovery Group Co. Business Overview
11.10.3 Horizon Discovery Group Co. CRISPR and Cas Genes Introduction
11.10.4 Horizon Discovery Group Co. Revenue in CRISPR and Cas Genes Business (2018-2023)
11.10.5 Horizon Discovery Group Co. Recent Development
11.11 Cellecta, Inc.
11.11.1 Cellecta, Inc. Company Detail
11.11.2 Cellecta, Inc. Business Overview
11.11.3 Cellecta, Inc. CRISPR and Cas Genes Introduction
11.11.4 Cellecta, Inc. Revenue in CRISPR and Cas Genes Business (2018-2023)
11.11.5 Cellecta, Inc. Recent Development
11.12 Agilent Technologies
11.12.1 Agilent Technologies Company Detail
11.12.2 Agilent Technologies Business Overview
11.12.3 Agilent Technologies CRISPR and Cas Genes Introduction
11.12.4 Agilent Technologies Revenue in CRISPR and Cas Genes Business (2018-2023)
11.12.5 Agilent Technologies Recent Development
11.13 Applied StemCell, Inc.
11.13.1 Applied StemCell, Inc. Company Detail
11.13.2 Applied StemCell, Inc. Business Overview
11.13.3 Applied StemCell, Inc. CRISPR and Cas Genes Introduction
11.13.4 Applied StemCell, Inc. Revenue in CRISPR and Cas Genes Business (2018-2023)
11.13.5 Applied StemCell, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Synthego
Thermo Fisher Scientific, Inc.
GenScript
Addgene
Merck
Integrated DNA Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.
OriGene Technologies, Inc.
New England Biolabs
Horizon Discovery Group Co.
Cellecta, Inc.
Agilent Technologies
Applied StemCell, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.